Insider Transactions in Q3 2016 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q3 2016)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2016
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
39,200
-100.0%
|
$2,430,400
$62.61 P/Share
|
|
Sep 01
2016
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
39,200
+50.0%
|
$1,293,600
$33.49 P/Share
|
|
Aug 10
2016
|
Clark Golestani EVP & Chief Info Officer |
SELL
Open market or private sale
|
Direct |
3,000
-17.56%
|
$189,000
$63.03 P/Share
|
|
Aug 05
2016
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
392,000
-16.46%
|
$23,912,000
$61.95 P/Share
|
|
Aug 05
2016
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
392,000
+19.16%
|
$12,936,000
$33.88 P/Share
|
|
Aug 04
2016
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,000
-28.14%
|
$399,000
$57.8 P/Share
|
|
Aug 02
2016
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,619
-4.31%
|
$93,902
$58.66 P/Share
|
|
Aug 02
2016
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
5,150
+12.06%
|
-
|
|
Aug 02
2016
|
Kenneth C Frazier Executive Chair |
SELL
Bona fide gift
|
Direct |
13,600
-2.6%
|
-
|
|
Jul 05
2016
|
Weir Mirian M Graddick Exe V-P, HR |
SELL
Open market or private sale
|
Direct |
45,000
-18.02%
|
$2,565,000
$57.96 P/Share
|
|
Jul 05
2016
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
27,621
-5.02%
|
$1,602,018
$58.0 P/Share
|
|
Jul 05
2016
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
27,621
+4.78%
|
$1,408,671
$51.02 P/Share
|
|
Jul 01
2016
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
32,379
-5.84%
|
$1,877,982
$58.0 P/Share
|
|
Jul 01
2016
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
32,379
+5.51%
|
$1,651,329
$51.02 P/Share
|
|
Jul 01
2016
|
Weir Mirian M Graddick Exe V-P, HR |
SELL
Open market or private sale
|
Direct |
30,000
-18.5%
|
$1,710,000
$57.49 P/Share
|
|
Jul 01
2016
|
Weir Mirian M Graddick Exe V-P, HR |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+15.61%
|
$1,200,000
$40.7 P/Share
|
|
Jul 01
2016
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,850,000
$57.69 P/Share
|
|
Jul 01
2016
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$2,200,000
$44.3 P/Share
|